Literature DB >> 36091620

Low-molecular-weight dextran-induced anaphylactic shock immediately after intracoronary imaging.

Kazuoki Dai1, Kuniomi Oi1, Yohei Hyodo1, Yusuke Jyuri1, Shin Takayama1, Mikio Shigehara1, Shunsuke Tomomori1, Tadanao Higaki1, Tomoharu Kawase1, Kazuyoshi Suenari1, Kenji Nishioka1, Masaya Otsuka1, Yoshiko Masaoka1, Nobuo Shiode1, Yukiko Nakano2.   

Abstract

Dextran has been frequently used during intracoronary imaging, such as in optical coherence tomography, optical frequent domain imaging, and coronary angioscopy. We report a case of dextran-induced anaphylaxis in a 70-year-old male with chronic coronary disease. Upon admission, we performed coronary angiography and coronary angioscopy on the patient. After the intracoronary imaging, the patient's blood pressure suddenly fell to 50 mmHg and a rash appeared on his chest. The patient was diagnosed as having dextran-induced anaphylactic shock. Epinephrine was administered repeatedly, and his blood pressure gradually recovered after administering a total of 6 mg epinephrine. There was no recurrence of the anaphylactic shock, and the patient was discharged 12 days later. The incidence of dextran-induced anaphylactic reactions is extremely low; however, they can be fatal. The possibility of anaphylactic shock induced by dextran should be kept in mind by all cardiovascular interventionalists performing intracoronary imaging. Learning objective: Dextran has been frequently used during intracoronary imaging. We report on a case of dextran-induced anaphylaxis in a 70-year-old male with chronic coronary disease. While the incidence of dextran-induced anaphylactic reactions is extremely low, it can lead to fatal events. The possibility of anaphylactic shock induced by dextran should be kept in mind by all cardiovascular interventionalists while performing intracoronary imaging.
© 2022 Japanese College of Cardiology. Published by Elsevier Ltd. All rights reserved. All rights reserved.

Entities:  

Keywords:  Anaphylaxis; Coronary angioscopy; Dextran

Year:  2022        PMID: 36091620      PMCID: PMC9449738          DOI: 10.1016/j.jccase.2022.05.003

Source DB:  PubMed          Journal:  J Cardiol Cases        ISSN: 1878-5409


  7 in total

1.  Studies on the immunochemical basis of allergic reactions to dextran in man.

Authors:  E A KABAT; G M TURINO; A B TARROW; P H MAURER
Journal:  J Clin Invest       Date:  1957-07       Impact factor: 14.808

2.  Coronary angioscopic findings eight months after sirolimus-eluting stent implantation: a comparison between ST-elevation myocardial infarction and stable angina pectoris.

Authors:  Kazuoki Dai; Masaharu Ishihara; Ichiro Inoue; Takuji Kawagoe; Yuji Shimatani; Satoshi Kurisu; Yasuharu Nakama; Tatsuya Maruhashi; Eisuke Kagawa; Toshiyuki Aokage; Junichi Matsushita; Hiroki Ikenaga
Journal:  EuroIntervention       Date:  2010-06       Impact factor: 6.534

3.  Dextrans.

Authors:  J D Paull
Journal:  Dev Biol Stand       Date:  1987

4.  Anaphylactoid reactions to Dextran 40 and 70: reports to the United States Food and Drug Administration, 1969 to 2004.

Authors:  Craig E Zinderman; Laurence Landow; Robert P Wise
Journal:  J Vasc Surg       Date:  2006-04-05       Impact factor: 4.268

5.  Pretreatment with dextran 1 makes dextran 40 therapy safer.

Authors:  Karl-Gösta Ljungström
Journal:  J Vasc Surg       Date:  2006-05       Impact factor: 4.268

6.  Adverse reactions to dextran in Sweden 1970-1979.

Authors:  K G Ljungström; H Renck; K Strandberg; H Hedin; W Richter; E Widerlöv
Journal:  Acta Chir Scand       Date:  1983

7.  JCS 2018 Guideline on Diagnosis of Chronic Coronary Heart Diseases.

Authors:  Masakazu Yamagishi; Nagara Tamaki; Takashi Akasaka; Takanori Ikeda; Kenji Ueshima; Shiro Uemura; Yutaka Otsuji; Yasuki Kihara; Kazuo Kimura; Takeshi Kimura; Yoshiki Kusama; Shinichiro Kumita; Hajime Sakuma; Masahiro Jinzaki; Hiroyuki Daida; Yasuchika Takeishi; Hiroshi Tada; Taishiro Chikamori; Kenichi Tsujita; Kunihiko Teraoka; Kenichi Nakajima; Tomoaki Nakata; Satoshi Nakatani; Akihiko Nogami; Koichi Node; Atsushi Nohara; Atsushi Hirayama; Nobusada Funabashi; Masaru Miura; Teruhito Mochizuki; Hiroyoshi Yokoi; Kunihiro Yoshioka; Masafumi Watanabe; Toshihiko Asanuma; Yuichi Ishikawa; Takahiro Ohara; Koichi Kaikita; Tokuo Kasai; Eri Kato; Hiroshi Kamiyama; Masaaki Kawashiri; Keisuke Kiso; Kakuya Kitagawa; Teruhito Kido; Toshio Kinoshita; Tomonari Kiriyama; Teruyoshi Kume; Akira Kurata; Satoshi Kurisu; Masami Kosuge; Eitaro Kodani; Akira Sato; Yasutsugu Shiono; Hiroki Shiomi; Junichi Taki; Masaaki Takeuchi; Atsushi Tanaka; Nobuhiro Tanaka; Ryoichi Tanaka; Takuya Nakahashi; Takehiro Nakahara; Akihiro Nomura; Akiyoshi Hashimoto; Kenshi Hayashi; Masahiro Higashi; Takafumi Hiro; Daisuke Fukamachi; Hitoshi Matsuo; Naoya Matsumoto; Katsumi Miyauchi; Masao Miyagawa; Yoshitake Yamada; Keiichiro Yoshinaga; Hideki Wada; Tetsu Watanabe; Yukio Ozaki; Shun Kohsaka; Wataru Shimizu; Satoshi Yasuda; Hideaki Yoshino
Journal:  Circ J       Date:  2021-02-16       Impact factor: 2.993

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.